Stefano Schena, MD, PhD

Publications

• Long-term outcomes of heparin-induced thrombocytopenia after cardiac surgery

  (Rodriguez E, Daskam M, Shou BL, Woodrum C, Gupta R, Dane KE, Alejo D, Sussman M, Schena S.) JTCVS Open. February 2025;23:190-198 SCOPUS ID: 2-s2.0-85214461915 02/01/2025

• Local epicardial robotic-enhanced hybrid ablation efficacy predictors for persistent atrial fibrillation

  (Celentano E, Cristiano E, Schena S, Gasparri M, Ignatiuk B, Renda M, Bia E, Rainone R, Graniero A, Giroletti L, Agnino A, De Groot NMS.) Heart Rhythm O2. 2025 SCOPUS ID: 2-s2.0-85214281997 01/01/2025

• Impact of intraoperative blood products, fluid administration, and persistent hypothermia on bleeding leading to reexploration after cardiac surgery.

  (Shou BL, Zhou AL, Ong CS, Alejo DE, DiNatale JM, Larson EL, Lawton JS, Schena S.) J Thorac Cardiovasc Surg. 2024 Sep;168(3):873-884.e4 PMID: 37839660 SCOPUS ID: 2-s2.0-85176239432 10/16/2023

• Robotic-enhanced hybrid ablation for persistent and long-standing atrial fibrillation: Early assessment of feasibility, safety, and efficacy.

  (Schena S, Lindemann J, Carlson A, Wilcox T, Oujiri J, Berger M, Gasparri M.) JTCVS Tech. 2024 Jun;25:81-93 PMID: 38899102 PMCID: PMC11184487 06/20/2024

• A model for delivery of extracorporeal life support in a stand-alone veterans affairs medical center.

  (Seadler BD, Melamed J, Sow M, Rogers AL, Syed A, Linsky PL, Ubert HA, Schena S, Durham LA, Almassi GH.) Artif Organs. 2024 Jun;48(6):675-682 PMID: 38321771 SCOPUS ID: 2-s2.0-85184427783 02/07/2024

• Early Reexploration for Postoperative Bleeding in Cardiac Surgery Is Beneficial Regardless of Bleeding Site, Even When Undetectable.

  (Shou BL, Schena S.) Ann Thorac Surg. 2024 Feb;117(2):484 PMID: 37178859 SCOPUS ID: 2-s2.0-85181087207 05/14/2023

• Robotic-enhanced hybrid ablation for persistent and long-standing atrial fibrillation: Early assessment of feasibility, safety, and efficacy

  (Schena S, Lindemann J, Carlson A, Wilcox T, Oujiri J, Berger M, Gasparri M.) JTCVS Techniques. June 2024;25:81-93 SCOPUS ID: 2-s2.0-85188775647 06/01/2024

• Changes in aorta hemodynamics in Left-Right Type 1 bicuspid aortic valve patients after replacement with bioprosthetic valves: An in-silico study.

  (Bailoor S, Seo JH, Schena S, Mittal R.) PLoS One. 2024;19(4):e0301350 PMID: 38626136 PMCID: PMC11020955 SCOPUS ID: 2-s2.0-85190733036 04/16/2024

• Changes in aorta hemodynamics in Left-Right Type 1 bicuspid aortic valve patients after replacement with bioprosthetic valves: An in-silico study

  (Bailoor S, Seo JH, Schena S, Mittal R.) PLoS ONE. April 2024;19(4 April) SCOPUS ID: 2-s2.0-85190733036 04/01/2024

• Two Posterior Mitral Leaflets or a Feature of Degenerative Valve Disease That Contributes to Mitral Regurgitation?

  (Barta LE, Holland HK, Costa HA, Rzepka JW, Almassi GH, Schena S, Pagel PS.) J Cardiothorac Vasc Anesth. 2023 Sep;37(9):1822-1825 PMID: 37225549 SCOPUS ID: 2-s2.0-85159893731 05/25/2023

• The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.

  (Yesantharao PS, Etchill EW, Zhou AL, Ong CS, Metkus TS, Canner JK, Alejo DE, Aliu O, Czarny MJ, Hasan RK, Resar JR, Schena S.) Catheter Cardiovasc Interv. 2023 Jun;101(7):1193-1202 PMID: 37102376 SCOPUS ID: 2-s2.0-85156229698 04/27/2023

• Balancing carcinoid crisis and right ventricular dysfunction during tricuspid and pulmonic valve replacement for carcinoid heart disease: A case report.

  (Pagryzinski AR, Schena S, Novalija J, Almassi GH, Pagel PS, Hang D.) Int J Surg Case Rep. 2023 Jan;102:107855 PMID: 36610355 PMCID: PMC9829749 SCOPUS ID: 2-s2.0-85145728191 01/08/2023